Piper Sandler Reiterates Overweight on OrthoPediatrics, Raises Price Target to $25

Benzinga Newsdesk www.benzinga.com Positive 55.7%

Neg 0% Neu 0% Pos 55.7%

Piper Sandler analyst Matt O'Brien reiterates OrthoPediatrics (NASDAQ:KIDS) with a Overweight and raises the price target from $22 to $25.